Short-course oral co-trimoxazole versus intramuscular benzathine benzylpenicillin for impetigo in a highly endemic region: an open-label, randomised, controlled, non-inferiority trial

[1]  Mehrulnisa Alam,et al.  Therapeutic Guidelines: Antibiotic. Version 15. , 2015 .

[2]  E. Kaplan,et al.  Benzathine Penicillin G for the Management of RHD: Concerns About Quality and Access, and Opportunities for Intervention and Improvement. , 2013, Global heart.

[3]  M. Chatfield,et al.  Comparison of three methods for the recovery of skin pathogens from impetigo swabs collected in a remote community of Northern Territory, Australia. , 2013, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[4]  J. Carapetis,et al.  Clinic Attendances during the First 12 Months of Life for Aboriginal Children in Five Remote Communities of Northern Australia , 2013, PloS one.

[5]  Bernadette A. Thomas,et al.  Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[6]  M. McDonald,et al.  Is Streptococcus pyogenes Resistant or Susceptible to Trimethoprim-Sulfamethoxazole? , 2012, Journal of Clinical Microbiology.

[7]  T. Parks,et al.  Streptococcal skin infection and rheumatic heart disease , 2012, Current opinion in infectious diseases.

[8]  Y. Sharma,et al.  Streptococcus pyogenes pharyngitis & impetigo in a rural area of Panchkula district in Haryana, India , 2012, The Indian journal of medical research.

[9]  A. Cheng,et al.  Acute post-streptococcal glomerulonephritis in the Northern Territory of Australia: a review of 16 years data and comparison with the literature. , 2011, The American journal of tropical medicine and hygiene.

[10]  S. Cosgrove,et al.  Erratum: Staphylococcus aureus infections in adults and children (Clinical Infectious Diseases (2011) 52:3 (e18-e55)) , 2011 .

[11]  J. Turnidge.  Trimethoprim, Co-Trimoxazole (Co-T) and Related Agents , 2010 .

[12]  J. Carapetis,et al.  Rheumatic fever in Indigenous Australian children , 2010, Journal of paediatrics and child health.

[13]  M. McDonald,et al.  Trimethoprim‐sulfamethoxazole compared with benzathine penicillin for treatment of impetigo in Aboriginal children: A pilot randomised controlled trial , 2010, Journal of paediatrics and child health.

[14]  J. Carapetis,et al.  A Regional Initiative to Reduce Skin Infections amongst Aboriginal Children Living in Remote Communities of the Northern Territory, Australia , 2009, PLoS neglected tropical diseases.

[15]  J. Carapetis,et al.  High Burden of Impetigo and Scabies in a Tropical Country , 2009, PLoS neglected tropical diseases.

[16]  R. Hay,et al.  Oral amoxicillin vs. oral erythromycin in the treatment of pyoderma in Bamako, Mali: an open randomized trial , 2007, International journal of dermatology.

[17]  J. Carapetis,et al.  The global burden of group A streptococcal diseases. , 2005, The Lancet. Infectious diseases.

[18]  J. C. van der Wouden,et al.  Treatment for impetigo , 2004, BMJ : British Medical Journal.

[19]  M. McDonald,et al.  Acute rheumatic fever: a chink in the chain that links the heart to the throat? , 2004, The Lancet. Infectious diseases.

[20]  R. Maleszka,et al.  Penetration of cotrimoxazole components into skin after a single oral dose. Theoretical versus experimental approach. , 2004, Polish journal of pharmacology.

[21]  D. Pashen.  CARPA Standard Treatment Manual - A clinical manual for primary health care practitioners in remote and rural communities in Central and Northern Australia. 4th ed. , 2004 .

[22]  J. Carapetis,et al.  Skin infections and infestations in Aboriginal communities in northern Australia , 2000, The Australasian journal of dermatology.

[23]  J. Carapetis,et al.  Clinical and epidemiological features of group A streptococcal bacteraemia in a region with hyperendemic superficial streptococcal infection , 1999, Epidemiology and Infection.

[24]  S. Skull,et al.  Investigation of a cluster of Staphylococcus aureus invasive infection in the top end of the Northern Territory. , 1999, Australian and New Zealand journal of medicine.

[25]  B. Currie.  Are the currently recommended doses of benzathine penicillin G adequate for secondary prophylaxis of rheumatic fever? , 1996, Pediatrics.

[26]  J. Mathews,et al.  Strategies for and Problems Associated with Maximising and Monitoring Compliance with Antibiotic Treatment for Otitis Media with Effusion in a Remote Aboriginal Community , 1994 .

[27]  W. Grubb,et al.  Emergence of high-level mupirocin resistance in methicillin-resistant Staphylococcus aureus in Western Australia. , 1994, The Journal of hospital infection.

[28]  H. Dillon,et al.  Further studies on the treatment of streptococcal skin infection. , 1970, The Journal of pediatrics.

[29]  M. Markowitz,et al.  The treatment of pyoderma in children. , 1970, JAMA.

[30]  H. Dillon,et al.  The treatment of streptococcal skin infections. , 1970, The Journal of pediatrics.

[31]  S. Tong,et al.  Community-associated methicillin-resistant Staphylococcus aureus skin infections in the tropics. , 2011, Dermatologic clinics.

[32]  Sara E Cosgrove,et al.  Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  J. McCarthy,et al.  Kucers' The Use of Antibiotics , 2010 .

[34]  A. Verhagen,et al.  Interventions for impetigo. , 2004, The Cochrane database of systematic reviews.